Dermapharm Holding Balance Sheet Health
Financial Health criteria checks 3/6
Dermapharm Holding has a total shareholder equity of €521.4M and total debt of €1.1B, which brings its debt-to-equity ratio to 207.6%. Its total assets and total liabilities are €2.1B and €1.6B respectively. Dermapharm Holding's EBIT is €256.2M making its interest coverage ratio 9.4. It has cash and short-term investments of €110.8M.
Key information
207.6%
Debt to equity ratio
€1.08b
Debt
| Interest coverage ratio | 9.4x |
| Cash | €110.78m |
| Equity | €521.40m |
| Total liabilities | €1.59b |
| Total assets | €2.11b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DMPD's short term assets (€602.2M) exceed its short term liabilities (€300.3M).
Long Term Liabilities: DMPD's short term assets (€602.2M) do not cover its long term liabilities (€1.3B).
Debt to Equity History and Analysis
Debt Level: DMPD's net debt to equity ratio (186.3%) is considered high.
Reducing Debt: DMPD's debt to equity ratio has increased from 147.8% to 207.6% over the past 5 years.
Debt Coverage: DMPD's debt is well covered by operating cash flow (28.1%).
Interest Coverage: DMPD's interest payments on its debt are well covered by EBIT (9.4x coverage).